Degenerative myelopathy (DM) is characterized by progressive degeneration of the spinal cord and affects selected dog breeds \[[@r1], [@r5], [@r6]\]. The etiology of DM has not yet been fully elucidated; however, a previous study reported that DM-affected dogs were homozygous for the *A* allele of a superoxide dismutase 1 (*SOD1*) missense mutation, *SOD1:c.118G \>A*, which predicts a p.E40K amino acid substitution \[[@r2]\]. Most of the dogs examined in previous studies were old large breeds \[[@r1], [@r8]\]. The clinical signs of DM initially appear in the pelvic limbs as spastic upper motor neuron (UMN) paresis and general proprioceptive ataxia, which eventually progress to flaccid tetraplegia and dysphagia \[[@r1], [@r5], [@r6], [@r10], [@r11], [@r15]\]. With a longer disease duration, these dogs exhibited signs of respiratory muscle paralysis and were considered to have died from respiratory failure \[[@r12], [@r13]\]. An increasing number of Pembroke Welsh Corgis (PWCs) in Japan have been found to carry the homozygous *SOD1* mutation and display a typical clinical course \[[@r4]\]. The PWC is smaller than other predisposed large breed dogs, allowing many owners to give appropriate care for a longer period of time \[[@r5], [@r10]\]. However, the clinical signs of DM in the late stage, especially changes in respiratory function, have not yet been documented in detail.

In the present study, we investigated changes in arterial blood gas parameters in DM-affected PWCs over progressive disease stages. We also determined whether changes in the thoracic and abdominal movement patterns during breathing reflected a decline in respiratory function with disease progression. We hypothesized that hypoventilation progressively develops in dogs in the later stages of DM due to paralysis of the respiratory muscles, with respiratory patterns mirroring the state of respiratory function.

All cases had been referred to the Animal Medical Center of Gifu University. Informed and written consent was obtained from the owners of the cases at their first visit. We included PWCs that met the following criteria; clinical signs consistent with DM (slowly progressive, non-painful, paraparesis to tetraplegia) \[[@r6]\] unremarkable findings on spinal imaging with non-contrast computed tomography and/or magnetic resonance imaging (MRI), unremarkable findings on cerebrospinal fluid (CSF) analyses (total cell count and cytology) and genetic testing proving homozygosity for the *SOD1* mutation (*c.118G \>A* missense). The MRI studies included T1- and T2-weighted sagittal images, T1- and T2-weighted transverse images, and post-contrast T1 sagittal and transverse images of the thoracic and lumbar spinal cords. The disease stage of the DM cases at each visit was classified into 4 clinical stages as previously described \[[@r6], [@r10], [@r11], [@r15]\] with a minor modification. The clinical characteristics of the stages were as follows; Stage1, upper motor neuron paraparesis and general proprioceptive ataxia; Stage2, nonambulatory paraparesis to paraplegia; Stage3, lower motor neuron paraplegia to thoracic limb paresis; and Stage4, lower motor neuron tetraplegia and brain stem signs. In addition to flaccid tetraplegia, PWCs with nonambulatory tetraparesis were grouped into stage 4. At each visit, cases received physical examination and complete neurological examination. Periodically, CBC, serum biochemistry and thoracic radiography were performed in some cases to ensure that pulmonary disorders do not underlie respiratory impairment.

Arterial blood specimens were collected from the femoral artery into a heparinized syringe. Samples were immediately analyzed using either GEM ^®^Premier 3000 (IL Janan Co., Ltd., Tokyo, Japan) or i-STAT 300F (Abbott Japan Co., Ltd., Chiba, Japan). Sampling was only undertaken when the dogs showed normal breathing at rest; sampling was suspended if panting continued. To evaluate respiratory function, we focused on the arterial partial pressure of oxygen (PaO~2~), arterial partial pressure of carbon dioxide (PaCO~2~) and alveolar-arterial (A-a) gradient. The A-a gradient was calculated using the following equation \[[@r14]\]:

A-a gradient=(149.73-\[PaCO~2~/0.8\])-PaO~2~

To analyze breathing patterns, dogs were held in a right-lateral recumbency, and at least ten cycles of breathing were videotaped horizontally from the ventral side ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.The position and points measured to determine breathing patterns. Thoracic movement was measured at the vertical line connecting both axillas (A). Abdominal movement was measured at the vertical line passing the caudal edge of the 13th rib (B).). The distance between the dog and video camera was kept constant to 50 cm in all measurements. Three pairs of images at maximal inspiration and expiration were captured from the movies and used to quantify the expansion ratio of the rib cage and abdomen during breathing. Our preliminary study determined 2 points to be measured for thoracic and abdominal movements during which the largest changes in width were observed. The ratios of movement at the maximal inspiratory level against the maximal expiratory level were calculated for the thorax and abdomen, and the mean values were calculated.

Descriptive statistics were analyzed for normality using the Shapiro-Wilk test. Analytes with a normal distribution (PaO~2~, A-a DO2, and thoracic and abdominal movements) were compared using a one-way ANOVA, followed by the Tukey-Kramer's honestly significant difference test as a post hoc analysis for multiple comparisons. Analytes with a non-normal distribution (PaCO~2~) were compared by the Kruskal-Wallis test, followed by the Steel-Dwass test as a post hoc analysis for multiple comparisons. The Pearson product-moment correlation was used to evaluate the relationship between PaO~2~ and thoracic or abdominal movement. The Spearman rank order correlation was used to evaluate the relationship between PaCO~2~ and thoracic or abdominal movement. A *p* value \<0.05 was considered significant. All statistical analyses were performed by JMP^®^10 (SAS Institute Inc., Cary, NC, U.S.A.).

A total of 19 PWCs were included in this study. Eleven dogs were male, 8 of which were castrated, and 8 dogs were female, 5 of which were spayed. The age at the first measurement ranged from 9.7 to 13.6 years (median, 11.3 years). Body weight ranged from 8.8 to 17.7 kg (median, 12.9 kg). A summary of information on these dogs is presented in [Table 1](#tbl_001){ref-type="table"}Table 1.Dogs examined in the present studyNo.SexAge of onset (years)First measurmentNumber of data obtained from each caseArterial blood gas analysisAnalysis, of breathing patternAge (years)Body weight (kg)StageTotalStageTotal123412341M10.310.711.5152614022592MC9.39.717.5133310010343FS8.810.313.301427002134MC9.010.512.523207002025MC8.310.511.2023056MC12.513.317.7022047F9.610.79.1031048MC10.611.311.2121049FS11.412.013.4130041000110F10.310.413.5111031000111MC10.913.015.00011212MC10.411.514.0002020010113F11.311.415.00020214FS12.312.88.8110021000115FS9.09.711.92000216M11.312.015.32000217MC11.313.612.90001118FS10.812.012.60100119M10.310.310.11000110001Total number of data in each stage132724134379F, female; FS, female spayed; M, male; MC, male castrated. Dog numbers 1, 2, 3 and 17 underwent necropsy and were histologically diagnosed with DM.. To identify changes in respiratory function, an arterial blood gas analysis was performed on 19 PWCs clinically diagnosed with DM (of these, 4 PWCs were histologically diagnosed with DM during the study period).

The oxygenation state was evaluated by measuring PaO~2~. Hypoxemia was defined as PaO~2~ values lower than 80 mmHg \[[@r9]\]. The oxygenation states of dogs in stages 1 and 2 were considered normal ([Fig. 2A](#fig_002){ref-type="fig"}Fig. 2.Respiratory function and breathing patterns. (A, B) States of oxygenation and ventilation in DM. (A) PaO~2~ was significantly lower in stage 4 than in the other stages, with 76.9% of PWCs being hypoxemic. (B) PaCO~2~ was significantly higher in stage 4 than in the other stages, with 53.8% of PWCs developing hypoventilation. (C, D) Thoracic and abdominal movements during breathing. (C) Thoracic movement was more likely to be smaller in the later stages. (D) Abdominal movement was more likely to be larger in the later stages. \* *P*\<0.05, \*\* *P*\<0.01.). As the disease progressed to the later stages, 8.3% of dogs in stage 3 and 76.9% of dogs in stage 4 were considered to be hypoxemic ([Fig. 2A](#fig_002){ref-type="fig"}). PaO~2~ values were significantly lower in stage 4 than in the other stages (respectively, *P*\<0.0001). The arterial blood gas analysis also provided information regarding the alveolar ventilation status by measuring PaCO~2~. Hypercapnia, which suggests hypoventilation, was defined as PaCO~2~ values greater than 45 mmHg \[[@r9]\]. The ventilation status of the dogs in stages 1 and 2 was considered normal ([Fig. 2B](#fig_002){ref-type="fig"}). With disease progression, 4.2% of dogs in stage 3 and 53.8% of dogs in stage 4 were considered to have developed hypoventilation ([Fig. 2B](#fig_002){ref-type="fig"}). PaCO~2~ values were significantly higher in stage 4 than in the other stages (stage 1, *P*=0.0009; stage 2, *P*=0.0003; and stage 3, *P*=0.0019). Furthermore, 58.3% of the dogs that were hypoxemic also developed hypoventilation. This result suggested that hypoxemia occurred in DM-affected PWCs due to hypoventilation. The mean values of the A-a gradient were 21.0 ± 6.9 in stage 1, 20.4 ± 7.0 in stage 2, 21.6 ± 8.5 in stage 3 and 18.3 ± 7.8 in stage 4. No significant differences were observed in the A-a gradient values among the 4 stages.

Thoracic and abdominal movements during breathing were quantified in the different stages. Nine PWCs clinically diagnosed with DM (of these, 3 PWCs were histologically diagnosed with DM) were included in this analysis ([Table 1](#tbl_001){ref-type="table"}). No significant differences were observed in the degrees of thoracic and abdominal movements between stages 1 and 2 ([Fig. 2C](#fig_002){ref-type="fig"} and 2D). With disease progression, thoracic movement decreased and became significantly lower in stage 4 than in stages 1 (*P*=0.0023) and 2 (*P*=0.0011) ([Fig. 2C](#fig_002){ref-type="fig"}). In contrast, abdominal movement increased in stages 3 and 4; however, a significant difference was only noted between stages 1 and 4 (*P*=0.0497) ([Fig. 2D](#fig_002){ref-type="fig"}).

To evaluate whether changes in thoracic and abdominal movements correlated with respiratory impairment, a correlation analysis was performed between thoracic or abdominal movement and PaO~2~ or PaCO~2~ values. The correlation coefficient between thoracic movement and PaO~2~ was 0.7590 (*P*\<0.0001) ([Fig. 3A](#fig_003){ref-type="fig"}Fig. 3.Relationship between thoracic or abdominal movement and PaO~2~ or PaCO~2~. Thoracic movement correlated with (A) PaO~2~ and (B) PaCO~2~. Abdominal movement correlated with (C) PaO~2~ and (D) PaCO~2~.), and PaCO~2~ was −0.6583 (*P*=0.0006) ([Fig. 3B](#fig_003){ref-type="fig"}). This result indicated that respiratory impairment progressed as thoracic movement decreased. The correlation coefficient between abdominal movement and PaO~2~ was −0.6525 (*P*=0.0007) ([Fig. 3C](#fig_003){ref-type="fig"}), and PaCO~2~ was 0.6183 (*P*=0.0017) ([Fig. 3D](#fig_003){ref-type="fig"}). This result showed that abdominal movement increased with the progression of respiratory impairment.

DM is a progressive neurodegenerative disease that ultimately leads to respiratory failure and death \[[@r12], [@r13]\]. However, respiratory dysfunction in DM and its progression have not yet been examined in detail. Therefore, we evaluated changes in respiratory function in DM-affected PWCs. Our results suggested that thoracic movement during breathing declined in the later stages of DM, resulting in hypoxemia due to hypoventilation.

A normal A-a gradient value excluded conditions, such as a true shunt, ventilation/perfusion mismatch and diffusion impairment. A previous study demonstrated that hypoxemic dogs with a normal gradient value developed hypoxemia due to hypoventilation \[[@r14]\]. The A-a gradient value of dogs without cardiopulmonary diseases was previously reported to be 21.8 ± 6.4 \[[@r3]\], and the 95% confidence interval was from 9.0 to 34.6. In the present study, the A-a gradient values of dogs in all stages were within the reported reference range. Therefore, hypoxemia was considered to have occurred due to hypoventilation in DM PWCs.

A previous study on the mechanics of canine inspiratory muscles reported that the diaphragm and intercostal muscles acted synergistically for lung expansion, in which the lung volume during combined diaphragm-intercostal contractions was greater than the sum of the lung volumes produced by two muscles contracting separately \[[@r7]\]. In our study, thoracic movement declined in stages 3 and 4. This result supported previously reported atrophic changes in the intercostal muscles in stages 3 and 4 in PWCs leading to progressive respiratory impairment \[[@r10]\]. PWCs in stage 3 showed the widest ranges in thoracic movement. This variability may reflect the wide spectrum of functional states of the intercostal muscles of DM cases in stage 3, from almost normal to nearly paralytic states. In our study, thoracic movement negatively correlated with PaO~2~ and positively correlated with PaCO~2~. These results indicated that the dysfunction in the intercostal muscles produced insufficient thoracic expansion, resulting in hypoventilation and subsequently hypoxemia. In contrast to thoracic movement, abdominal movement increased as DM progressed to the later stages, and respiratory movement consequently changed to the abdominal breathing pattern. This change in the breathing pattern suggested that the diaphragm maintained respiratory function to compensate for decreased thoracic movement. Ultimately, pathological changes develop in the diaphragm, such as paralysis and/or fatigue, and dogs may die from respiratory failure. However, the pathology of the diaphragm and phrenic nerves has not yet been investigated in DM-affected dogs.

No prophylactic or curative treatment currently exists for DM \[[@r6]\]. Therefore, treatments should be aimed to relieve clinical signs and maintain the quality of life of the affected dogs. Since PWCs are more likely to be maintained until the later stages of DM than large breeds \[[@r5], [@r10]\], it is important to consider appropriate care for the decreased respiratory function. For example, DM-affected dogs in the later stages that show an abdominal breathing pattern may not be able to regulate their body temperature by panting, which requires constriction of the intercostal muscles and diaphragm. Therefore, the temperature of the environment in which the dogs are kept needs to be considered in order to avoid panting and maintain maximum respiratory function. The results on longitudinal changes in respiratory function in the present study will assist veterinary practitioners and owners to recognize when and how to give appropriate care for DM-affected dogs.
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